TrialInternational journal of chronic obstructive pulmonary disease2018

Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT).

Kai M Beeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.